Evidence map›Paper›PMID 36381248›Full record

ArticleJournal of orthopaedic translation2023

1-2 ​T static magnetic field combined with Ferumoxytol prevent unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis.

Gejing Zhang, Chenxiao Zhen, Jiancheng Yang, Zheyuan Zhang, Youde Wu, Jingmin Che, Peng Shang

Open access · goldAbstract read
In one paragraph

Article in Journal of orthopaedic translation, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
5.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 27 citations in OpenAlex.

  1. Trial
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Review
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Gejing ZhangSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
Chenxiao ZhenSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
Jiancheng YangDepartment of Osteoporosis, Honghui Hospital, Xi'an Jiaotong University, Xi'an, 710054, China.
Zheyuan ZhangSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
Youde WuSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
Jingmin CheSchool of Life Sciences, Northwestern Polytechnical University, Xi'an, Shaanxi, 710072, China.
Peng ShangResearch & Development Institute of Northwestern Polytechnical University, Shenzhen, 518057, China.
Northwestern Polytechnical University · CNXi'an Honghui Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: With the deepening of magnetic biomedical effects and electromagnetic technology, some medical instruments based on static magnetic field (SMF) have been used in orthopedic-related diseases treatment. Studies have shown SMF could combat osteoporosis by regulating the differentiation of mesenchymal stem cells (MSCs), osteoblast and osteoclast. With the development of nanotechnology, iron oxide nanoparticles (IONPs) have been reported to regulate the process of bone anabolism. As for SMF combined with IONPs, studies indicated osteogenic differentiation of MSCs were promoted by the combination of SMF and IONPs. However, there are few reports on the effects of SMF combined with IONPs on osteoclast. Herein, the purpose of this study was to investigate the effects of high static magnetic field (HiSMF) combined with IONPs on unloading-induced bone loss Methods: Results: Conclusions: Synthetically, our research illustrated 1-2 ​T SMF combined with IONPs prevented unloading-induced bone loss by regulating iron metabolism in osteoclastogenesis.

Indexed as

BMC, Bone mineral contentBMD, Bone mineral densityBone lossBV/TV, Bone volume/tissue volumeCt.Ar, Cortical areaCt.Ar/Tt.Ar, Cortical area to total areaFerumoxytolFPN, FerroproteinFTH1, Ferritin heavy polypeptide 1HiSMF, High static magnetic fieldsHyMF, Hypomagnetic fieldIONPs, Iron oxide nanoparticlesIron metabolismMAR, Mineral apposition rateMDA, MalondialdehydeMMP9, Matrix metalloproteinase-9MRI, Magnetic resonance imagingMSCs, Mesenchymal stem cellsNFATC1, Nuclear factor of activated T cells 1N.Ob/BS, The number of osteoblast per bone surfaceN.Oc/BS, The number of osteoclast per bone surfaceOsteoclastogenesisOVX, OvariectomizedRANKL, Receptor activator of nuclear factor κ-B ligandROI, Region of interestROS, Reactive oxygen speciesSMF, Static magnetic fieldSOD, Superoxide dismutaseSR-A I/II, Scavenger receptors type A I/IIStatic magnetic fieldT-AOC, Total Antioxidant CapacityTb.N, Trabecular numberTb.Sp, Trabecular separationTb.Th, Trabecular thicknessTfR1, Transferrin receptor 1TMD, Tissue mineral densityTRAP5b, Tartrate-resistant acid phosphatase 5bTt.Ar, Total cross-sectional area

Identifiers

PMID36381248
PMCPMC9646753
OpenAlexW4308903031

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.